Hyku Biosciences Appoints John Gustofson to its Board of Directors John Gustofson, MS, MBA appointed to the Board of Directors The appointment is in conjunction with Chugai Venture Fund joining syndicate with an investment that brings Hyku’s total seed financing to...

Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase of Growth Kleem Chaudhary, Ph.D. appointed as President and Chief Executive Officer Dr. Chaudhary brings more than 20 years of leadership experience across multiple pharmaceutical and biotechnology companies ...